arrow
J

Jeffery J. Auletta

nationwide children's hospital
H指数:40
被引数:5,180

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Comprehensive Donor Analysis

移植后环磷酰胺时代的造血细胞移植结局:全面的供者分析

2026-10-230
OAAI
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

HLA错配无关供者减低强度移植后移植抗宿主病预防的术后环磷酰胺方案II期研究:ACCESS试验扩展队列结果

2026-09-010
OAAI
Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS Trial

不匹配无关供者造血细胞移植中的感染负担:ACCESS试验的结果

2026-07-160
OA
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

异基因移植前急性髓系白血病中可测量的残留突变NPM1

2025-11-240
OAAI
Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective

造血干细胞移植后中心静脉导管拔除:综述与展望

2025-11-010
PRE
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

匹配无关供者与半合子相合供者造血细胞移植使用移植后环磷酰胺

2025-10-080
OAAI
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377

勘误表:Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532;文章编号:JTCT-S-25-00377

2025-10-070
PRE
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients

医师对造血细胞移植和细胞治疗的倡导:克服挑战以减少患者差异并改善预后

2025-09-260
PRE
Proceedings from the Second Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant

第二届“重塑护理者”研讨会论文集:探讨造血细胞移植的护理者需求

2025-09-110
PREAI
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant

整合肺和系统性转录组以表征儿童造血干细胞移植后的肺损伤

2025-09-090
OA
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis

tisagenleucel治疗后B-Cell ALL患者感染的实时世界结局:一项CIBMTR分析

2025-08-050
OAAI
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR

异基因造血细胞供者选择:NMDP/CIBMTR当代指南

2025-07-010
PREAI
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children’s Oncology Group (ACCL1633)

一项评估植物乳杆菌 Lactiplantibacillus plantarum 预防GI aGvHD的随机临床试验:来自儿童肿瘤组(ACCL1633)的报告

2025-07-010
PRE
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

CD19嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后的感染:CIBMTR的真实世界分析

2025-05-300
OAAI
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR

造血细胞移植和细胞治疗领域的当前活动趋势与成果——CIBMTR报告

2025-05-190
PRE